Val Adams

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Key Events

Jun 24, 2026TrialOptimizing Ancillary Therapies (Acetaminophen, Cannabis, Antihistamines, and NSAIDS) With Immune Checkpoint Inhibitors for Solid Tumors (OAT ICI)

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Regulatory

Regulatory Timeline

19821 event

FDAJan 1

Calan — ISOPTIN

Application NDA018485 (NDA)

19842 events

FDAMar 30

Calan — VERAPAMIL HYDROCHLORIDE

Application NDA018925 (NDA)

FDAMar 30

Calan — CALAN

Application NDA019038 (NDA)

19871 event

FDANov 23

Calan — ISOPTIN

Application NDA018593 (NDA)

19881 event

FDAFeb 23

Calan — CALAN

Application NDA018817 (NDA)

19901 event

FDAMay 29

Calan — VERELAN

Application NDA019614 (NDA)

19911 event

FDAMar 6

Calan — CALAN SR

Application NDA019152 (NDA)

19961 event

FDAFeb 26

Calan — COVERA-HS

Application NDA020552 (NDA)

19981 event

FDANov 25

Calan — VERELAN PM

Application NDA020943 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)